These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 22907585)
1. Decreased PADI4 mRNA association with global hypomethylation in hepatocellular carcinoma during HBV exposure. Zhang C; Fan L; Fan T; Wu D; Gao L; Ling Y; Zhu J; Li R; Wei L Cell Biochem Biophys; 2013 Mar; 65(2):187-95. PubMed ID: 22907585 [TBL] [Abstract][Full Text] [Related]
2. Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma. Zhang C; Xu Y; Zhao J; Fan L; Jiang G; Li R; Ling Y; Wu M; Wei L Ann Surg Oncol; 2011 Aug; 18(8):2373-80. PubMed ID: 21331808 [TBL] [Abstract][Full Text] [Related]
3. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118 [TBL] [Abstract][Full Text] [Related]
4. [Plasma sB7-H3 serves as an assistant diagnostic marker for hepatitis B virus-associated hepatocellular carcinoma]. Xu W; Li F; Yu L; Liu J; He X; Fan R; Chen W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):744-7. PubMed ID: 25001942 [TBL] [Abstract][Full Text] [Related]
5. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma]. Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257 [TBL] [Abstract][Full Text] [Related]
6. Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation. Zhang F; Wu LM; Zhou L; Chen QX; Xie HY; Feng XW; Zheng SS Ann Surg Oncol; 2008 Dec; 15(12):3494-502. PubMed ID: 18830757 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Fukai K; Yokosuka O; Chiba T; Hirasawa Y; Tada M; Imazeki F; Kataoka H; Saisho H Cancer Res; 2003 Dec; 63(24):8674-9. PubMed ID: 14695180 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463 [TBL] [Abstract][Full Text] [Related]
9. iTRAQ-coupled 2-D LC-MS/MS analysis of protein profile associated with HBV-modulated DNA methylation. Niu D; Sui J; Zhang J; Feng H; Chen WN Proteomics; 2009 Aug; 9(15):3856-68. PubMed ID: 19639599 [TBL] [Abstract][Full Text] [Related]
10. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma. Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884 [TBL] [Abstract][Full Text] [Related]
11. The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma. Ling Y; Zhu J; Gao L; Liu Y; Zhu C; Li R; Wei L; Zhang C BMC Med Genet; 2013 Jan; 14():14. PubMed ID: 23347460 [TBL] [Abstract][Full Text] [Related]
12. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells. Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855 [TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells. Chan DW; Lee JM; Chan PC; Ng IO Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis. Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900 [TBL] [Abstract][Full Text] [Related]
15. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications. Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of Toll-like receptor 7 expression in hepatitis-virus-related human hepatocellular carcinoma. Lin KJ; Lin TM; Wang CH; Liu HC; Lin YL; Eng HL Hum Pathol; 2013 Apr; 44(4):534-41. PubMed ID: 23069256 [TBL] [Abstract][Full Text] [Related]
17. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282 [TBL] [Abstract][Full Text] [Related]
18. The silencing of RECK gene is associated with promoter hypermethylation and poor survival in hepatocellular carcinoma. Zhang C; Ling Y; Zhang C; Xu Y; Gao L; Li R; Zhu J; Fan L; Wei L Int J Biol Sci; 2012; 8(4):451-8. PubMed ID: 22419890 [TBL] [Abstract][Full Text] [Related]
19. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma. Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684 [TBL] [Abstract][Full Text] [Related]
20. [Expression of CAS in hepatocellular carcinoma tissues and its relationship with HBV infection]. Zang H; Zhao JM; Ji D; Sun YL; Zhou GD; Zhao YL; Chen GF Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):285-7. PubMed ID: 23189846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]